Evatanepag
CAS No. 223488-57-1
Evatanepag( CP-533536 free acid )
Catalog No. M24016 CAS No. 223488-57-1
Evatanepag is an EP2 receptor selective prostaglandin E2 (PGE2) agonist that induces local bone formation with EC50 of 0.3 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 170 | In Stock |
|
| 5MG | 155 | In Stock |
|
| 10MG | 250 | In Stock |
|
| 25MG | 432 | In Stock |
|
| 50MG | 607 | In Stock |
|
| 100MG | 830 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEvatanepag
-
NoteResearch use only, not for human use.
-
Brief DescriptionEvatanepag is an EP2 receptor selective prostaglandin E2 (PGE2) agonist that induces local bone formation with EC50 of 0.3 nM.
-
DescriptionEvatanepag is an EP2 receptor selective prostaglandin E2 (PGE2) agonist that induces local bone formation with EC50 of 0.3 nM.CP-533536 demonstrated the ability to heal fractures when administered locally as a single dose in rat models of fracture healing.
-
In VitroEvatanepag (10 nM, 30 min) inhibits hFcεRI-induced mast cells degranulation in a dose-dependent manner.Evatanepag (0.1 nM-10 μM, 12 min) results in an equivalent increase in intracellular cAMP in HEK-293 cells, with an IC50 of 50 nM.
-
In VivoEvatanepag (0.3-3.0 mg/kg, directly injected into the marrow cavity of the tibia) promotes bone formation in rats.Evatanepag (0.3, 3.0 mg/kg, intranasal administration, from day1 to day4) reduces HDM aeroallergen-induced increased RL response to methacholine in mice.Evatanepag (1 mg/kg, intravenous injection) demonstrates high i.v. clearance (Cl: 56 mL/min/kg) and a short half-life (t1/2: 0.33 h). Animal Model:Rats Dosage:0.3, 1.0, 3.0 mg/kg Administration:Directly injected into the marrow cavity of the tibia Result:Dose-dependently increased in bone area, bone mineral content, bone mineral density.Animal Model:HDM (house dust mite)-sensitized BALB/c mice Dosage:0.3 mg/kg, 3 mg/kg Administration:Intranasal administration, from day1 to day4.Result:Prevented aeroallergen-driven increased RL (lung resistance) at 0.3 mg/kg. Prevented the enhanced MC activity by approximately 48% at 3 mg/kg.
-
SynonymsCP-533536 free acid
-
PathwayGPCR/G Protein
-
TargetProstaglandin Receptor
-
RecptorPGE2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number223488-57-1
-
Formula Weight468.57
-
Molecular FormulaC25H28N2O5S
-
Purity>98% (HPLC)
-
SolubilityDMSO:32 mg/mL (68.29 mM)
-
SMILESO=C(O)COC1=CC=CC(CN(CC2=CC=C(C(C)(C)C)C=C2)S(=O)(C3=CC=CN=C3)=O)=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Cameron KO, et al. Discovery of CP-533536: an EP2 receptor selective prostaglandin E2 (PGE2) agonist that induces local bone formation. Bioorg Med Chem Lett. 2009 Apr 1;19(7):2075-8.
molnova catalog
related products
-
GW 627368X
GW627368(GW627368X) is a novel, potent and selective competitive antagonist of prostanoid EP4 receptor(Ki= 100 nM) with additional human TP receptor affinity(Ki= 150 nM).
-
Bupivacaine hydrochl...
Bupivacaine hydrochloride binds to the intracellular portion of voltage-gated sodium channels and blocks sodium influx into nerve cells.
-
Prostaglandin E2 (PG...
Prostaglandin E2 is a hormone-like substance that participate in a wide range of body functions such as the contraction and relaxation of smooth muscle the dilation and constriction of blood vessels control of blood pressure and modulation of inflammation.
Cart
sales@molnova.com